Frequency, mutual exclusivity and clinical associations of myositis autoantibodies in a combined European cohort of idiopathic inflammatory myopathy patients.

However, whilst cancer was more common in our anti -NXP2 positive group in comparison to the rest of the cohort (13.5% vs 9.5% for CAM and 17.1% vs 14.2% for cancer-ever), this did not reach statistical significance.

also in 111,027 other papers